Célèste Lebbé
Impact in
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Polyomavirus and related diseases
- Cutaneous Melanoma Detection and Management
- Viral-associated cancers and disorders
- Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
- Oncology 338
- Cancer Immunotherapy and Biomarkers 104
- CAR-T cell therapy research 93
- Cutaneous Melanoma Detection and Management 86
- Polyomavirus and related diseases 56
- Viral-associated cancers and disorders 48
-
- Melanoma and MAPK Pathways 119
- Co-authors
- Omid Hamid (38 shared papers)Jeffrey S. Weber (19 shared papers)Jedd D. Wolchok (23 shared papers)Axel Hoos (10 shared papers)Michele Maio (21 shared papers)Steven O’Day (9 shared papers)F. Stephen Hodi (11 shared papers)Jean‐Jacques Grob (55 shared papers)
- Journals
- Journal of Clinical Oncology (98 papers)Annals of Oncology (44 papers)European Journal of Cancer (26 papers)Melanoma Research (24 papers)Cancers (16 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Célèste Lebbé
509 papers receiving 18.0k citations
Célèste Lebbé's Hit Papers
Peers
Comparison fields: 5 of 144
- Oncology 11.3k
- Immunology 3.7k
- Dermatology 1.2k
- Pathology and Forensic Medicine 1.3k
- Pulmonary and Respiratory Medicine 2.2k
Countries citing papers authored by Célèste Lebbé
This map shows the geographic impact of Célèste Lebbé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Célèste Lebbé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Célèste Lebbé more than expected).
Fields of papers citing papers by Célèste Lebbé
This network shows the impact of papers produced by Célèste Lebbé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Célèste Lebbé. The network helps show where Célèste Lebbé may publish in the future.
Co-authors
The 25 scholars most cited alongside Célèste Lebbé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 547 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria Hit paper breakdown → | 2009 | 2322 |
| 2 | Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial Hit paper breakdown → | 2016 | 940 |
| 3 | Ipilimumab monotherapy in patients with pretreated advanced melanoma: a randomised, double-blind, multicentre, phase 2, dose-ranging study Hit paper breakdown → | 2009 | 939 |
| 4 | Dabrafenib plus trametinib in patients with BRAFV600-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial Hit paper breakdown → | 2017 | 490 |
| 5 | Randomized, Open-Label Phase II Study Evaluating the Efficacy and Safety of Talimogene Laherparepvec in Combination With Ipilimumab Versus Ipilimumab Alone in Patients With Advanced, Unresectable Melanoma Hit paper breakdown → | 2017 | 482 |
| 6 | Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature Hit paper breakdown → | 2017 | 404 |
| 7 | Merkel cell carcinoma Hit paper breakdown → | 2017 | 390 |
| 8 | Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline Hit paper breakdown → | 2015 | 377 |
| 9 | Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline Hit paper breakdown → | 2015 | 344 |
| 10 | 2013 | 340 | |
| 11 | 2013 | 338 | |
| 12 | 2018 | 271 | |
| 13 | 2016 | 264 | |
| 14 | 2019 | 253 | |
| 15 | 2016 | 247 | |
| 16 | 2018 | 238 | |
| 17 | 1998 | 213 | |
| 18 | 2007 | 194 | |
| 19 | 2014 | 157 | |
| 20 | 2013 | 139 |
About Célèste Lebbé
Célèste Lebbé is a scholar working on Oncology, Molecular Biology, Immunology, Epidemiology and Dermatology, having authored 547 papers that have together received 18.3k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (119 papers), Cancer Immunotherapy and Biomarkers (104 papers), CAR-T cell therapy research (93 papers), Cutaneous Melanoma Detection and Management (86 papers), Polyomavirus and related diseases (56 papers), Immunotherapy and Immune Responses (51 papers), Viral-associated cancers and disorders (48 papers) and Nonmelanoma Skin Cancer Studies (31 papers). The work is most often cited by research in Oncology (11.3k citations), Immunology (3.7k citations), Dermatology (1.2k citations), Pathology and Forensic Medicine (1.3k citations) and Pulmonary and Respiratory Medicine (2.2k citations). Célèste Lebbé has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Omid Hamid, Jeffrey S. Weber, Jedd D. Wolchok, Axel Hoos, Michele Maio, Steven O’Day, F. Stephen Hodi, Jean‐Jacques Grob, Rachel Humphrey and Oliver Bohnsack. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer, Melanoma Research and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.